Table 1.
CSH18 | CSH71 | ||
---|---|---|---|
Hut78 | 3.4 | 0.033 | CTCL |
HL60 | 3 | 0.73 | AML |
MOLT4 | 0.24 | 0.29 | ALL |
K562 | 0.54 | 0.27 | CML |
CCRF‐CEM | 0.1 | 0.05 | AML |
SR | 0.11 | 0.27 | Lymphoma |
RPMI‐8226 | 7.8 | 4.8 | MM |
CSH18 | CSH71 | ||
---|---|---|---|
Hut78 | 3.4 | 0.033 | CTCL |
HL60 | 3 | 0.73 | AML |
MOLT4 | 0.24 | 0.29 | ALL |
K562 | 0.54 | 0.27 | CML |
CCRF‐CEM | 0.1 | 0.05 | AML |
SR | 0.11 | 0.27 | Lymphoma |
RPMI‐8226 | 7.8 | 4.8 | MM |